The limit set for fully subsidising interferon- for MS in New Zealand has been reached

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.307, 2001-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A decision has been made to make -interferon free of charge to certain MS patients in New Zealand

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 248, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Lamivudine [`Zeffix'; Glaxo Wellcome] has been launched in a new indication in New Zealand

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Reclassification of orlistat [Xenical; Roche] as a pharmacist-only medicine has been recommended in New Zealand (NZ)

Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

A 23% market share of new prescriptions for hepatitis C in the US has been captured by Roche's antiviral agent PEG-interferon (IFN)- -2a

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 402, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

A new campaign for better access to psychological therapies has been launched in the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 599, 2010-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite